Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
The CRAC channel inhibitor Auxora Reprograms Pathogenic Alveolar Macrophage-T Cell Circuits in Viral Pneumonia.
Journal: The Journal of clinical investigation
Published: July 28, 2026
CRAC channels as targets for immunotherapy.
Journal: Current opinion in immunology
Published: January 21, 2026
Zegocractin for acute pancreatitis with systemic inflammatory response syndrome: a randomized, controlled, dose-ranging, phase 2b trial.
Journal: EClinicalMedicine
Published: September 22, 2025
Bench to Bedside: Translating Discoveries to Clinical Care in Kidney Disease.
Journal: Nephron
Published: August 18, 2025
Inhibition of Calcium Release-Activated Calcium Channels to Treat Acute Kidney Injury: Design and Rationale of the KOURAGE Study a Randomized Trial.
Journal: American journal of nephrology
Published: November 24, 2024
Orai1 calcium channel inhibition prevents progression of chronic pancreatitis.
Journal: JCI insight
Published: December 05, 2022
Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trial.
Journal: Critical care (London, England)
Published: January 07, 2022
Derivation and validation of the ED-SAS score for very early prediction of mortality and morbidity with acute pancreatitis: a retrospective observational study.
Journal: BMC emergency medicine
Published: September 10, 2020
Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial.
Journal: Critical care (London, England)
Published: June 26, 2020
Microglial Calcium Release-Activated Calcium Channel Inhibition Improves Outcome from Experimental Traumatic Brain Injury and Microglia-Induced Neuronal Death.
Journal: Journal of neurotrauma
Published: October 24, 2018
Last Updated: 09/26/2026